Fig. 2
From: PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma
Overexpression of PDCL3 in LIHC. A Expression levels of PDCL3 in LIHC tumor tissues and normal tissues. B Expression levels of PDCL3 in LIHC (hepatocellular carcinoma) and matched adjacent normal tissues. C–E Relationship between PDCL3 overexpression and clinical, pathological, and histological staging. F Correlation of PDCL3 with overall survival rate. G PDCL3 staining from IHC results provided by the HPA database. *p value < 0.05; **p value < 0.01; ***p value < 0.001 (Student’s t test)